AgenciesIndia’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.
The company said a booster dose was given to trial participants six months after they received their second dose.
The company said a booster dose was given to trial participants six months after they received their second dose.
Read More News on
(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.